STAT

A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission

Fewer doctors would have to wait for permission to prescribe addiction treatment drugs under a new, bipartisan bill.
Under a new bill co-authored by Rep. Paul Tonko (D-N.Y.), the practice of “prior authorization” would be banned in state Medicaid programs for addiction treatment medicines like buprenorphine.

WASHINGTON — Fewer doctors would have to wait for permission to prescribe addiction treatment drugs under new, bipartisan legislation being unveiled this week by two lawmakers on the House Energy and Commerce Committee.

Under a new bill authored by Reps. Paul Tonko (D-N.Y.) and David McKinley (R-W.Va.), the practice of “prior authorization,” in which insurers require doctors to seek approval before they can proceed with a prescription or

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks